Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (842)
2023 (887)
2022 (831)
2021 (892)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (244)
2011 (163)
2010 (139)
2000 (2)
1977 (2)
All (8489)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
Tobiasson M
JSON
CSV
XLSX
TXT
Family name
Tobiasson
Given name
Magnus
Initials
M
ORCID
ORCID
0000-0002-3633-5852
Affiliations
Department of Hematology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
5 publications
PubMed
DOI
Crossref
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
Tobiasson M
, Pandzic T, Illman J, ..., Dybedal I,
Hellström-Lindberg E
J Clin Oncol
42
(12) 1378-1390 [2024-04-20; online 2024-01-17]
Clinical Genomics Uppsala [Collaborative]
PubMed
DOI
Crossref
Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation.
Dimitriou M
, Mortera-Blanco T,
Tobiasson M
, ...,
Woll PS
,
Jacobsen SEW
Blood
143
(11) 953-966 [2024-03-14; online 2023-12-14]
NGI Short read [Service]
NGI Uppsala (SNP&SEQ Technology Platform) [Service]
National Genomics Infrastructure [Service]
PubMed
DOI
Crossref
Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts.
Todisco G
,
Creignou M
,
Bernard E
, ...,
Papaemmanuil E
,
Hellström-Lindberg E
Clin. Cancer Res.
29
(20) 4256-4267 [2023-10-13; online 2023-07-27]
Bioinformatics Support for Computational Resources [Service]
Bioinformatics Support, Infrastructure and Training [Collaborative]
PubMed
DOI
Crossref
Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation.
Jädersten M, Boriskina K, Lindholm C, ..., Mielke S,
Tobiasson M
Leuk. Lymphoma
-
(-) 1-4 [2021-11-15; online 2021-11-15]
Clinical Genomics Uppsala [Collaborative]
PubMed
DOI
Crossref
Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 - azacitidine induces only lymphoma remission.
Tobiasson M
, Pandzic T,
Cavelier L
, Sander B, Wahlin BE
Leuk. Lymphoma
60
(13) 3316-3319 [2019-12-00; online 2019-06-17]
Clinical Genomics Uppsala [Collaborative]
SciLifeLab Data Centre
Publications
9.5.1